BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011; 17(7): 867-897 [PMID: 21412497 DOI: 10.3748/wjg.v17.i7.867] [Cited by in CrossRef: 119] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Ghatnekar O, Andersson R, Svensson M, Persson U, Ringdahl U, Zeilon P, Borrebaeck CA. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int J Cancer. 2013;133:2392-2397. [PMID: 23649606 DOI: 10.1002/ijc.28256] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
2 Wang X, Xiao L, Yu H. Expression levels of long non-coding RNA HOXA distal transcript antisense RNA and metabotropic glutamate receptor 1 in pancreatic carcinoma, and their prognostic values. Oncol Lett 2018;15:9464-70. [PMID: 29844833 DOI: 10.3892/ol.2018.8519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, Kornprat P, AlZoughbi W, Seggewies FS, Lackner C, Stojakovic T, Samonigg H, Hoefler G, Pichler M. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109:416-421. [PMID: 23799847 DOI: 10.1038/bjc.2013.332] [Cited by in Crossref: 274] [Cited by in F6Publishing: 289] [Article Influence: 30.4] [Reference Citation Analysis]
4 Wu W, Zhao L, Yu Y, Hu H, Shi H, Jia Q, Du L. Heparanase expression in blood is sensitive to monitor response to anticancer treatment in pancreatic cancer, a pilot study. Pancreatology 2018;18:100-5. [PMID: 29153700 DOI: 10.1016/j.pan.2017.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Schlick K, Magnes T, Huemer F, Ratzinger L, Weiss L, Pichler M, Melchardt T, Greil R, Egle A. C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients. J Clin Med. 2019;8. [PMID: 31717722 DOI: 10.3390/jcm8111791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Sandrasegaran K, Nutakki K, Tahir B, Dhanabal A, Tann M, Cote GA. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. AJR Am J Roentgenol. 2013;201:1002-1008. [PMID: 24147470 DOI: 10.2214/ajr.12.10170] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
7 Xu C, Li Y, Dong M, Wu X, Wang X, Xiao Y. Inhibitory effect of Schisandra chinensis leaf polysaccharide against L5178Y lymphoma. Carbohydrate Polymers 2012;88:21-5. [DOI: 10.1016/j.carbpol.2011.11.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
8 Vasilescu AM, Andriesi Rusu DF, Bradea C, Vlad N, Lupascu-Ursulescu C, Cianga Spiridon IA, Trofin AM, Tarcoveanu E, Lupascu CD. Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology. Life (Basel) 2021;11:1216. [PMID: 34833092 DOI: 10.3390/life11111216] [Reference Citation Analysis]
9 Gao CT, Ren J, Yu J, Li SN, Guo XF, Zhou YZ. KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target. Ann Transl Med 2020;8:1394. [PMID: 33313139 DOI: 10.21037/atm-20-1970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Rossier C, Dunet V, Matzinger O, Prior J. TEP/TDM en radiothérapie : indications et perspectives. Cancer/Radiothérapie 2012;16:152-63. [DOI: 10.1016/j.canrad.2012.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
11 Zhang LJ, Wang KB, Liu LS, Chen LZ, Peng BG, Liang LJ, Li Z, Xue L, Li W, Xia JT. Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. BMC Cancer 2014;14:571. [PMID: 25104140 DOI: 10.1186/1471-2407-14-571] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
12 Liu W, Huo Y, Yang J, Fu X, Yang M, Tao L, Liu D, Zhang J, Hua R, Sun Y. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients. Oncol Lett 2018;15:9287-92. [PMID: 29844826 DOI: 10.3892/ol.2018.8452] [Reference Citation Analysis]
13 Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis. World J Gastroenterol 2013; 19(29): 4808-4817 [PMID: 23922481 DOI: 10.3748/wjg.v19.i29.4808] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
14 Miyashita T, Miki K, Kamigaki T, Makino I, Nakagawara H, Tajima H, Takamura H, Kitagawa H, Fushida S, Ahmed AK, Duncan MD, Harmon JW, Ohta T. Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer. Clin Exp Med 2017;17:19-31. [PMID: 26449615 DOI: 10.1007/s10238-015-0394-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ye S, Bai L. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma. Cancer Manag Res 2018;10:3405-17. [PMID: 30237742 DOI: 10.2147/CMAR.S173444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Shin EJ, Canto MI. Pancreatic cancer screening. Gastroenterol Clin North Am. 2012;41:143-157. [PMID: 22341255 DOI: 10.1016/j.gtc.2011.12.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
17 Ji L, Gong C, Ge L, Song L, Chen F, Jin C, Zhu H, Zhou G. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma. Exp Ther Med 2017;13:551-9. [PMID: 28352330 DOI: 10.3892/etm.2016.3968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhou DD, Liu XF, Lu CW, Pant OP, Liu XD. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer. Cell Prolif. 2017;50. [PMID: 29027279 DOI: 10.1111/cpr.12398] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
19 Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73-85. [PMID: 26830752 DOI: 10.1016/s0140-6736(16)00141-0] [Cited by in Crossref: 995] [Cited by in F6Publishing: 643] [Article Influence: 165.8] [Reference Citation Analysis]
20 Zhang J, Liu C, Mo X, Shi H, Li S. Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer. Oncol Lett 2018;15:1771-6. [PMID: 29434873 DOI: 10.3892/ol.2017.7512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
21 Wason MS, Colon J, Das S, Seal S, Turkson J, Zhao J, Baker CH. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine 2013;9:558-69. [PMID: 23178284 DOI: 10.1016/j.nano.2012.10.010] [Cited by in Crossref: 183] [Cited by in F6Publishing: 163] [Article Influence: 18.3] [Reference Citation Analysis]
22 Krüger J, Meffert PJ, Vogt LJ, Gärtner S, Steveling A, Kraft M, Mayerle J, Lerch MM, Aghdassi AA. Early Parenteral Nutrition in Patients with Biliopancreatic Mass Lesions, a Prospective, Randomized Intervention Trial. PLoS One 2016;11:e0166513. [PMID: 27861546 DOI: 10.1371/journal.pone.0166513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
23 Que R, Ding G, Chen J, Cao L. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol. 2013;11:219. [PMID: 24007214 DOI: 10.1186/1477-7819-11-219] [Cited by in Crossref: 138] [Cited by in F6Publishing: 142] [Article Influence: 15.3] [Reference Citation Analysis]
24 Hurton S, MacDonald F, Porter G, Walsh M, Molinari M. The current state of pancreatic cancer in Canada: incidence, mortality, and surgical therapy. Pancreas. 2014;43:879-885. [PMID: 24763076 DOI: 10.1097/mpa.0000000000000147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
25 Treadwell JR, Zafar HM, Mitchell MD, Tipton K, Teitelbaum U, Jue J. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis. Pancreas. 2016;45:789-795. [PMID: 26745859 DOI: 10.1097/mpa.0000000000000524] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 6.6] [Reference Citation Analysis]
26 Demirci NS, Dogan M, Erdem GU, Kacar S, Turhan T, Kilickap S, Cigirgan LC, Kayacetin E, Bozkaya Y, Zengin N. Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer? Saudi J Gastroenterol 2017;23:183-9. [PMID: 28611342 DOI: 10.4103/sjg.SJG_483_16] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Zeng J, Xiong Y, Zhang LB, Ruan JD, Wu W, Sun WJ. The antitumor activity of recombinant antitumor antiviral protein and the associated molecular mechanism in pancreatic tumor cells. Cancer Biother Radiopharm 2012;27:426-33. [PMID: 22783925 DOI: 10.1089/cbr.2012.1166] [Reference Citation Analysis]
28 Yang D, Wang D, Qiu Y, Tian X, Zuo D, Dong Y, Lou W, Wang W. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis. Clin Hemorheol Microcirc 2021. [PMID: 34602462 DOI: 10.3233/CH-211269] [Reference Citation Analysis]
29 Conti CB, Cereatti F, Drago A, Grassia R. Focal Autoimmune Pancreatitis: A Simple Flow Chart for a Challenging Diagnosis. Ultrasound Int Open 2020;6:E67-75. [PMID: 33490857 DOI: 10.1055/a-1323-4906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lu XX, Zhang SM, Fang Y, Wang ZT, Xie JJ, Zhan Q, Deng XX, Chen H, Jin JB, Peng CH. Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma. Tumour Biol. 2013;34:3339-3343. [PMID: 23749490 DOI: 10.1007/s13277-013-0903-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
31 Ito H, Tajiri T, Hiraiwa SI, Sugiyama T, Ito A, Shinma Y, Kaneko M, Anzai K, Tsuda S, Ichikawa H, Nagata J, Kojima S, Watanabe N. A Case of Rare Cutaneous Metastasis from Advanced Pancreatic Cancer. Case Rep Oncol. 2020;13:49-54. [PMID: 32110219 DOI: 10.1159/000505322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Eltawil KM, Renfrew PD, Molinari M. Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer. HPB (Oxford) 2012;14:260-8. [PMID: 22404265 DOI: 10.1111/j.1477-2574.2012.00441.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
33 Reitz D, Gerger A, Seidel J, Kornprat P, Samonigg H, Stotz M, Szkandera J, Pichler M. Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer. J Clin Pathol. 2015;68:427-433. [PMID: 25759406 DOI: 10.1136/jclinpath-2014-202451] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
34 Caba O, Prados J, Ortiz R, Jiménez-Luna C, Melguizo C, Alvarez PJ, Delgado JR, Irigoyen A, Rojas I, Pérez-Florido J, Torres C, Perales S, Linares A, Aránega A. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Dig Dis Sci 2014;59:2714-20. [PMID: 25069573 DOI: 10.1007/s10620-014-3291-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
35 Ma Y, Hu M, Zhou L, Ling S, Li Y, Kong B, Huang P. Long non-coding RNA HOTAIR promotes cancer cell energy metabolism in pancreatic adenocarcinoma by upregulating hexokinase-2. Oncol Lett 2019;18:2212-9. [PMID: 31452722 DOI: 10.3892/ol.2019.10551] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
36 Witt BL, Kristen Hilden RN, Scaife C, Chadwick B, Layfield L, Cory Johnston W, Safaee M, Siddiqui A, Adler DG. Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP. Diagn Cytopathol. 2013;41:682-688. [PMID: 23008113 DOI: 10.1002/dc.22924] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
37 Watanabe M, Sheriff S, Lewis KB, Cho J, Tinch SL, Balasubramaniam A, Kennedy MA. Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics. J Mol Biomark Diagn 2012;3:S3-002. [PMID: 26609466 DOI: 10.4172/2155-9929.S3-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
38 Ritchie SA, Chitou B, Zheng Q, Jayasinghe D, Jin W, Mochizuki A, Goodenowe DB. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. World J Gastroenterol 2015; 21(21): 6604-6612 [PMID: 26074698 DOI: 10.3748/wjg.v21.i21.6604] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
39 Ikemoto J, Serikawa M, Hanada K, Eguchi N, Sasaki T, Fujimoto Y, Sugiyama S, Yamaguchi A, Noma B, Kamigaki M, Minami T, Okazaki A, Yukutake M, Ishii Y, Mouri T, Shimizu A, Tsuboi T, Arihiro K, Chayama K. Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study. Diagnostics (Basel) 2021;11:287. [PMID: 33673151 DOI: 10.3390/diagnostics11020287] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Wu J, Song L, Zhang Y, Zhao DY, Guo B, Liu J. Efficacy of percutaneous transhepatic cholangiodrainage (PTCD) in patients with unresectable pancreatic cancer. Tumour Biol 2014;35:2753-7. [PMID: 24264311 DOI: 10.1007/s13277-013-1363-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Wang WG, Zhang Y, Wang L, Chen Y, Tian BL. Chronic pancreatic inflammatory granuloma caused by foreign body presenting as a pancreatic pseudotumor: A case report and literature review. Pancreatology 2015;15:573-5. [PMID: 26095151 DOI: 10.1016/j.pan.2015.05.474] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Park JS, Kim HM, Jeung HC, Kang SA. Association between early nutritional risk and overall survival in patients with advanced pancreatic cancer: A single-center retrospective study. Clin Nutr ESPEN 2019;30:94-9. [PMID: 30904235 DOI: 10.1016/j.clnesp.2019.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Sagami R, Nishikiori H, Anami K, Fujiwara S, Honda K, Ikuyama S, Kitano M, Murakami K. Utility of Endoscopic Ultrasonography Screening for Small Pancreatic Cancer and Proposal for a New Scoring System for Screening. Pancreas 2018;47:257-64. [PMID: 29329161 DOI: 10.1097/MPA.0000000000000988] [Reference Citation Analysis]
44 Doiron B, DeFronzo RA. A novel experimental model for human mixed acinar-ductal pancreatic cancer. Carcinogenesis 2018;39:180-90. [PMID: 29106450 DOI: 10.1093/carcin/bgx119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Auriemma WS, Berger AC, Bar-ad V, Boland PM, Cohen SJ, Roche-lima CMS, Morris GJ. Locally Advanced Pancreatic Cancer. Seminars in Oncology 2012;39:e9-e22. [DOI: 10.1053/j.seminoncol.2012.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
46 Zhu L, Shi X, Xue H, Wu H, Chen G, Sun H, He Y, Jin Z, Liang Z, Zhang Z. CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery. Medicine (Baltimore). 2016;95:e2664. [PMID: 26844495 DOI: 10.1097/md.0000000000002664] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
47 Gärtner S, Krüger J, Aghdassi AA, Steveling A, Simon P, Lerch MM, Mayerle J. Nutrition in Pancreatic Cancer: A Review. Gastrointest Tumors 2016;2:195-202. [PMID: 27403414 DOI: 10.1159/000442873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
48 Miyashita T, Tajima H, Makino I, Nakagawara H, Kitagawa H, Fushida S, Harmon JW, Ohta T. Metastasis-promoting role of extravasated platelet activation in tumor. Journal of Surgical Research 2015;193:289-94. [DOI: 10.1016/j.jss.2014.07.037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
49 Feng P, Cheng B, Wang ZD, Liu JG, Fan W, Liu H, Qi CY, Pan JJ. Application and progress of medical imaging in total mesopancreas excision for pancreatic head carcinoma. World J Gastrointest Surg 2021; 13(11): 1315-1326 [DOI: 10.4240/wjgs.v13.i11.1315] [Reference Citation Analysis]
50 Pang E, Yang R, Fu X, Liu Y. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumor Biol 2015;36:2403-7. [DOI: 10.1007/s13277-014-2850-8] [Cited by in Crossref: 119] [Cited by in F6Publishing: 130] [Article Influence: 14.9] [Reference Citation Analysis]
51 Kosmidis C, Sapalidis K, Kotidis E, Mixalopoulos N, Zarogoulidis P, Tsavlis D, Baka S, Man YG, Kanellos J. Pancreatic cancer from bench to bedside: molecular pathways and treatment options. Ann Transl Med 2016;4:165. [PMID: 27275478 DOI: 10.21037/atm.2016.05.11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
52 Kawase T, Yasui Y, Nishina S, Hara Y, Yanatori I, Tomiyama Y, Nakashima Y, Yoshida K, Kishi F, Nakamura M, Hino K. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. BMC Gastroenterol 2015;15:109. [PMID: 26330349 DOI: 10.1186/s12876-015-0340-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
53 Li Q, Lei C, Lu C, Wang J, Gao M, Gao W. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis 2019;10:698. [PMID: 31541081 DOI: 10.1038/s41419-019-1896-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
54 Kitagawa Y, Okumura K, Watanabe T, Tsukamoto K, Kitano S, Nankinzan R, Suzuki T, Hara T, Soda H, Denda T, Yamaguchi T, Nagase H. Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment. Sci Rep 2019;9:11346. [PMID: 31383871 DOI: 10.1038/s41598-019-47700-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
55 Iacobone M, Citton M, Nitti D. Laparoscopic distal pancreatectomy: Up-to-date and literature review. World J Gastroenterol 2012; 18(38): 5329-5337 [PMID: 23082049 DOI: 10.3748/wjg.v18.i38.5329] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
56 Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, Ni CR, Zhu MH. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol 2012; 18(8): 840-846 [PMID: 22371645 DOI: 10.3748/wjg.v18.i8.840] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
57 Engebretson A, Matrisian L, Thompson C. Pancreatic cancer: Patient and caregiver perceptions on diagnosis, psychological impact, and importance of support. Pancreatology 2015;15:701-7. [PMID: 26092655 DOI: 10.1016/j.pan.2015.05.471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
58 Sun X, Kong L, Li B, Zhang Y, Yang H. Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene. Cancer Manag Res 2018;10:5019-26. [PMID: 30464602 DOI: 10.2147/CMAR.S177243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
59 Karstensen JG, Cârţână T, Constantinescu C, Dumitrașcu S, Kovacevic B, Klausen P, Hassan H, Klausen TW, Bertani H, Bhutani MS, Săftoiu A, Vilmann P. Endoscopic ultrasound guided needle-based confocal laser endomicroscopy in solid pancreatic masses - a prospective validation study. Endosc Int Open 2018;6:E78-85. [PMID: 29344564 DOI: 10.1055/s-0043-121987] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
60 Dyrla P, Gil J, Florek M, Saracyn M, Grala B, Jędrzejewski E, Wojtuń S, Lubas A. Elastography in pancreatic solid tumours diagnoses. Prz Gastroenterol 2015;10:41-6. [PMID: 25960814 DOI: 10.5114/pg.2015.48994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
61 Mathison A, Salmonson A, Missfeldt M, Bintz J, Williams M, Kossak S, Nair A, de Assuncao TM, Christensen T, Buttar N, Iovanna J, Huebert R, Lomberk G. Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth By Inducing Mitotic Catastrophe. Mol Cancer Res 2017;15:984-97. [PMID: 28442587 DOI: 10.1158/1541-7786.MCR-17-0063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
62 McCormack DE, Mannal P, McDonald D, Tighe S, Hanson J, McFadden D. Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo. J Gastrointest Surg 2012;16:1136-43. [PMID: 22450950 DOI: 10.1007/s11605-012-1869-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
63 Aarnink A, Richard C, Truntzer C, Vincent J, Bengrine L, Vienot A, Borg C, Ghiringhelli F. Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma. Oncotarget 2018;9:25617-29. [PMID: 29876012 DOI: 10.18632/oncotarget.25424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
64 Wei W, Liu Y, Lu Y, Yang B, Tang L. LncRNA XIST Promotes Pancreatic CancerProliferation Through miR-133a/EGFR. J Cell Biochem. 2017;118:3349-3358. [PMID: 28295543 DOI: 10.1002/jcb.25988] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 22.8] [Reference Citation Analysis]
65 Zhang LL, He QK, Lv YN, Zhang ZJ, Xiang YK. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma. Chronobiol Int 2021;38:681-93. [PMID: 33691542 DOI: 10.1080/07420528.2021.1890760] [Reference Citation Analysis]
66 Yang SH, Guo JC, Yeh KH, Tien YW, Cheng AL, Kuo SH. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer. J Gastroenterol Hepatol 2016;31:2004-12. [PMID: 27059987 DOI: 10.1111/jgh.13395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
67 Kuzuu K, Misawa N, Ashikari K, Kessoku T, Kato S, Hosono K, Yoneda M, Nonaka T, Matsushima S, Komatsu T, Nakajima A, Higurashi T. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan. JAMA Netw Open 2021;4:e2126334. [PMID: 34546368 DOI: 10.1001/jamanetworkopen.2021.26334] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol 2016; 22(44): 9694-9705 [PMID: 27956793 DOI: 10.3748/wjg.v22.i44.9694] [Cited by in CrossRef: 517] [Cited by in F6Publishing: 459] [Article Influence: 86.2] [Reference Citation Analysis]
69 Zhang WX, Shi H, Xu JM. Survival and prognosis of patients with pancreatic carcinoma: an analysis of 156 cases. Shijie Huaren Xiaohua Zazhi 2011; 19(34): 3526-3531 [DOI: 10.11569/wcjd.v19.i34.3526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Imamura T, Okamura Y, Sugiura T, Yamamoto Y, Ito T, Ashida R, Ohgi K, Ohtsuka S, Uesaka K. ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients. Ann Surg Oncol 2021. [PMID: 33586063 DOI: 10.1245/s10434-021-09660-1] [Reference Citation Analysis]
71 Wang X, Dou N, Wang J, Zhang Y, Li Y, Gao Y. FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes. Int J Biol Sci 2021;17:915-25. [PMID: 33867818 DOI: 10.7150/ijbs.56733] [Reference Citation Analysis]
72 Mauriello C, Polistena A, Gambardella C, Tartaglia E, Orditura M, De Vita F, Santini L, Avenia N, Conzo G. Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study. Aging Clin Exp Res 2017;29:35-40. [PMID: 27837458 DOI: 10.1007/s40520-016-0657-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
73 Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012;51:3-13. [PMID: 22162227 DOI: 10.1002/mc.20785] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 11.6] [Reference Citation Analysis]
74 Syed AR, Carleton NM, Horne Z, Dhawan A, Bedi G, Kochhar G, Morrissey S, Williams H, Atkinson D, Schiffman S, Monga D, Lupetin A, Kirichenko A, Mitre M, Dhawan M, Kulkarni A, Thakkar S. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. J Gastrointest Cancer 2020;51:836-43. [PMID: 31605289 DOI: 10.1007/s12029-019-00303-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Fernández Aceñero MJ, Vázquez M, Esteban JM, García Diego G, Díaz Del Arco C. Influence of the Histopathological Features of the Lesion on the Diagnostic Yield of Fine-Needle Aspiration Cytology of Pancreatic Solid Lesions. Acta Cytol 2018;62:259-64. [PMID: 29705811 DOI: 10.1159/000488383] [Reference Citation Analysis]
76 Hu S, Huang W, Chen Y, Song Q, Lin X, Wang Z, Chen K. Spectral CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts: preliminary animal experience. Eur Radiol. 2014;24:2167-2173. [PMID: 24903229 DOI: 10.1007/s00330-014-3257-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
77 van der Gaag NA, Harmsen K, Eshuis WJ, Busch ORC, van Gulik TM, Gouma DJ. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death. Eur J Surg Oncol. 2014;40:551-558. [PMID: 24388408 DOI: 10.1016/j.ejso.2013.12.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
78 Feng Z, Chen P, Li K, Lou J, Wu Y, Li T, Peng C. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:650264. [PMID: 34631790 DOI: 10.3389/fmolb.2021.650264] [Reference Citation Analysis]
79 Rahman SH, Urquhart R, Molinari M. Neoadjuvant therapy for resectable pancreatic cancer. World J Gastrointest Oncol 2017; 9(12): 457-465 [PMID: 29290916 DOI: 10.4251/wjgo.v9.i12.457] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
80 Kyriazanos ID, Tsoukalos GG, Papageorgiou G, Verigos KE, Miliadis L, Stoidis CN. Local recurrence of pancreatic cancer after primary surgical intervention: how to deal with this devastating scenario? Surg Oncol 2011;20:e133-42. [PMID: 21576013 DOI: 10.1016/j.suronc.2011.04.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
81 Lou C, Zhao J, Gu Y, Li Q, Tang S, Wu Y, Tang J, Zhang C, Li Z, Zhang Y. LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway. J Cell Physiol 2020;235:3928-38. [PMID: 31608998 DOI: 10.1002/jcp.29288] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
82 Dababou S, Marrocchio C, Rosenberg J, Bitton R, Pauly KB, Napoli A, Hwang JH, Ghanouni P. A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound. J Ther Ultrasound 2017;5:9. [PMID: 28373906 DOI: 10.1186/s40349-017-0080-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
83 Gupta N, Yelamanchi R. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World J Gastroenterol 2021; 27(23): 3158-3181 [PMID: 34163104 DOI: 10.3748/wjg.v27.i23.3158] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Akasaka H, Mizushina Y, Yoshida K, Ejima Y, Mukumoto N, Wang T, Inubushi S, Nakayama M, Wakahara Y, Sasaki R. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells. Radiat Oncol 2016;11:153. [PMID: 27876069 DOI: 10.1186/s13014-016-0729-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
85 Lomberk GA, Urrutia R. The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure. Surg Clin North Am. 2015;95:935-952. [PMID: 26315515 DOI: 10.1016/j.suc.2015.05.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
86 Sato Y, Kobayashi T, Nishiumi S, Okada A, Fujita T, Sanuki T, Kobayashi M, Asahara M, Adachi M, Sakai A, Shiomi H, Masuda A, Yoshida M, Takeuchi K, Kodama Y, Kutsumi H, Nagashima K, Honda K. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers (Basel). 2020;12. [PMID: 32937962 DOI: 10.3390/cancers12092625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Malvezzi M, Carioli G, Bertuccio P, Negri E, La Vecchia C. Relation between mortality trends of cardiovascular diseases and selected cancers in the European Union, in 1970-2017. Focus on cohort and period effects. Eur J Cancer 2018;103:341-55. [PMID: 30029971 DOI: 10.1016/j.ejca.2018.06.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
88 Watanabe M, Sheriff S, Lewis KB, Tinch SL, Cho J, Balasubramaniam A, Kennedy MA. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer Lett 2012;315:18-27. [PMID: 22036895 DOI: 10.1016/j.canlet.2011.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
89 McCormack D, McFadden D. A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013;2013:575482. [PMID: 23691264 DOI: 10.1155/2013/575482] [Cited by in Crossref: 137] [Cited by in F6Publishing: 127] [Article Influence: 15.2] [Reference Citation Analysis]
90 Vanella G, Tamburrino D, Capurso G, Bronswijk M, Reni M, Dell'Anna G, Crippa S, Van der Merwe S, Falconi M, Arcidiacono PG. Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma. World J Gastroenterol 2022; 28(10): 976-984 [DOI: 10.3748/wjg.v28.i10.976] [Reference Citation Analysis]
91 Shida M, Chiba A, Ohashi M, Yamakawa M. Ultrasound Diagnosis and Treatment of Breast Lumps after Breast Augmentation with Autologous Fat Grafting. Plast Reconstr Surg Glob Open 2017;5:e1603. [PMID: 29632782 DOI: 10.1097/GOX.0000000000001603] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
92 Wei D, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS, Smith PG, Morgan MA, Sun Y. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res 2012;72:282-93. [PMID: 22072567 DOI: 10.1158/0008-5472.CAN-11-2866] [Cited by in Crossref: 113] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
93 Wang C, Xu R, Yuan Q, Wang Y, Shen D, Wang X, Gao W, Zhang H, Jiang H. Bioinformatics Method to Analyze the Mechanism of Pancreatic Cancer Disorder. Journal of Computational Biology 2013;20:444-52. [DOI: 10.1089/cmb.2012.0281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 McAuliffe JC, Christein JD. Type 2 diabetes mellitus and pancreatic cancer. Surg Clin North Am. 2013;93:619-627. [PMID: 23632148 DOI: 10.1016/j.suc.2013.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
95 Collins AL, Rock J, Malhotra L, Frankel WL, Bloomston M. Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma. Ann Surg Oncol 2012;19:2673-8. [PMID: 22461132 DOI: 10.1245/s10434-012-2337-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
96 Rosso T, Malvezzi M, Bosetti C, Bertuccio P, Negri E, La Vecchia C. Cancer mortality in Europe, 1970-2009: an age, period, and cohort analysis. Eur J Cancer Prev. 2018;27:88-102. [PMID: 27472086 DOI: 10.1097/cej.0000000000000282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
97 Carrato A, Melisi D, Prager G, Westphalen CB, Ferreras A, D'Esquermes N, Taieb J, Mercadé TM. Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer. Future Oncol 2021;17:1843-54. [PMID: 33663227 DOI: 10.2217/fon-2020-0749] [Reference Citation Analysis]
98 Ilić M, Vlajinac H, Marinković J, Kocev N. Pancreatic cancer mortality in Serbia from 1991-2010 - a joinpoint analysis. Croat Med J 2013;54:369-75. [PMID: 23986278 DOI: 10.3325/cmj.2013.54.369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
99 Nakayama M, Sasaki R, Ogino C, Tanaka T, Morita K, Umetsu M, Ohara S, Tan Z, Nishimura Y, Akasaka H, Sato K, Numako C, Takami S, Kondo A. Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo. Radiat Oncol 2016;11:91. [PMID: 27386977 DOI: 10.1186/s13014-016-0666-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
100 Torres OJ, Moraes-Junior JM, Fernandes Ede S. [Distal pancreatectomy with en-bloc celiac trunk resection for locally advanced pancreatic body cancer (Appleby procedure): case report]. Arq Bras Cir Dig 2013;26:151-3. [PMID: 24000032 DOI: 10.1590/s0102-67202013000200018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Dyrla P, Gil J, Kosik K, Schneditz D, Saracyn M, Niemczyk S, Lubas A. Doppler tissue perfusion measurement is a sensitive and specific tool for a differentiation between malignant and inflammatory pancreatic tumors. PLoS One 2019;14:e0215944. [PMID: 31034484 DOI: 10.1371/journal.pone.0215944] [Reference Citation Analysis]
102 Wang L, Gu F, Ma N, Zhang L, Bian JM, Cao HY. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma. Tumour Biol 2013;34:2309-13. [PMID: 23568706 DOI: 10.1007/s13277-013-0775-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
103 Stotz M, Barth DA, Riedl JM, Asamer E, Klocker EV, Kornprat P, Hutterer GC, Prinz F, Lackner K, Stöger H, Gerger A, Pichler M. The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer. Cancers (Basel) 2020;12:E1798. [PMID: 32635610 DOI: 10.3390/cancers12071798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. J Gastrointest Oncol. 2013;4:343-351. [PMID: 24294505 DOI: 10.3978/j.issn.2078-6891.2013.044] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
105 Yang B, He JP, Yuan ML, Li W, Jiao H, You X, Liu XR, Zhao J, Li CL, Fu XB, Liao ZY, Yi C. Percutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue for advanced pancreatic carcinoma: Case Report. Medicine (Baltimore) 2017;96:e8018. [PMID: 28906385 DOI: 10.1097/MD.0000000000008018] [Reference Citation Analysis]
106 Sofuni A, Tsuchiya T, Itoi T. Ultrasound diagnosis of pancreatic solid tumors. J Med Ultrason (2001) 2020;47:359-76. [PMID: 31420821 DOI: 10.1007/s10396-019-00968-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
107 Xie Z, Chen X, Li J, Guo Y, Li H, Pan X, Jiang J, Liu H, Wu B. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer. Oncotarget. 2016;7:25408-25419. [PMID: 27028998 DOI: 10.18632/oncotarget.8323] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 18.8] [Reference Citation Analysis]
108 Wu L, Guo W, Li Y, Cheng T, Yao Y, Zhang Y, Liu B, Zhong M, Li S, Deng X, Zhu W. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma]. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:1171-1178. [PMID: 30377133 DOI: 10.3969/j.issn.1673-4254.2018.10.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Liu F, Ma J, Wang K, Li Z, Jiang Q, Chen H, Li W, Xia J. High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma. J Cancer 2019;10:6252-60. [PMID: 31772658 DOI: 10.7150/jca.35443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
110 Lembeck AL, Posch F, Klocker EV, Szkandera J, Schlick K, Stojakovic T, Kornprat P, Lackner C, Gerger A, Stoeger H, Stotz M, Pichler M. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer. Clin Chem Lab Med 2019;57:740-4. [PMID: 30307891 DOI: 10.1515/cclm-2018-0016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
111 Ungaro A, Orsi F, Casadio C, Galdy S, Spada F, Cella CA, Tonno CD, Bonomo G, Vigna PD, Murgioni S, Frezza AM, Fazio N. Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report. Ecancermedicalscience. 2016;10:635. [PMID: 27170835 DOI: 10.3332/ecancer.2016.635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
112 Dyrla P, Lubas A, Gil J, Niemczyk S. Doppler tissue perfusion parameters in recognizing pancreatic malignant tumors: Doppler perfusion in pancreatic tumors. Journal of Gastroenterology and Hepatology 2016;31:691-5. [DOI: 10.1111/jgh.13193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
113 Molinari M, El-Tawil K, Swaid F, Fiorentini G, Bou-Samra P, Sharma C, Liu H, Rahman SH, Hurton S, Tsung A. Patients' treatment preferences for potentially resectable tumors of the head of the pancreas. HPB (Oxford) 2020;22:265-74. [PMID: 31501009 DOI: 10.1016/j.hpb.2019.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Adams MA, Anderson MA, Myles JD, Khalatbari S, Scheiman JM. Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy. J Gastrointest Oncol. 2012;3:309-313. [PMID: 23205306 DOI: 10.3978/j.issn.2078-6891.2011.050] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
115 Dyrla P, Gil J, Niemczyk S, Saracyn M, Kosik K, Czarkowski S, Lubas A. Elastography in the Diagnosis of Pancreatic Malignancies. In: Pokorski M, editor. Advances in Medicine and Medical Research. Cham: Springer International Publishing; 2019. pp. 41-8. [DOI: 10.1007/5584_2018_303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
116 Crispo A, Barba M, Malvezzi M, Arpino G, Grimaldi M, Rosso T, Esposito E, Sergi D, Ciliberto G, Giordano A, Montella M. Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy: Results from a joinpoint regression analysis. Cancer Biol Ther 2013;14:1113-22. [PMID: 24025410 DOI: 10.4161/cbt.26425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
117 Zhang SH, Wang J, Yang C, Wang B, Wu HS, Wang CY. Surgical selection for late pancreatic head carcinoma without gastric outlet obstruction. J Huazhong Univ Sci Technolog Med Sci 2013;33:866-9. [PMID: 24337850 DOI: 10.1007/s11596-013-1213-9] [Reference Citation Analysis]
118 Karakas Y, Lacin S, Yalcin S. Recent advances in the management of pancreatic adenocarcinoma. Expert Review of Anticancer Therapy 2018;18:51-62. [DOI: 10.1080/14737140.2018.1403319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
119 Moon JH, Shin JS, Hong SW, Jung SA, Hwang IY, Kim JH, Choi EK, Ha SH, Kim JS, Kim KM, Hong DW, Kim D, Kim YS, Kim JE, Kim KP, Hong YS, Choi EK, Lee JS, Hattersley M, Jin DH, Kim TW. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer. Oncotarget 2015;6:26895-908. [PMID: 26314849 DOI: 10.18632/oncotarget.4822] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]